NeuroGeneration: Pioneering Neural Stem Cell TherapiesContact UsLinksSite Map  
 
About NeuroGenerationWhat is Stem Cell Therapy?Clinical DevelopmentNews & EventsInvestors
   

NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
News & Events

September 25, 2012

NeuroGeneration recruits top neuroscientiest to lead new Division in La Jolla....PRESS RELEASE

 

December 13, 2010

NeuroGeneration invited speaker at Shanghai's International Regenerative Medicine and Stem Cells..PRESS RELEASE

 

June 17, 2010

NeuroGeneration's Paper Highlighed at International Parkinson's Society Meeting ....read more: PRESS RELEASE

 

Clinical Trials

NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.

 

   
 
 
Healthy Websites